Biomerica (NASDAQ:BMRA) Issues Quarterly Earnings Results

Biomerica (NASDAQ:BMRA) released its earnings results on Tuesday. The company reported ($0.06) earnings per share for the quarter, Zacks reports. Biomerica had a negative return on equity of 84.62% and a negative net margin of 111.89%.

Biomerica Price Performance

Shares of BMRA stock opened at $0.35 on Thursday. Biomerica has a 1-year low of $0.24 and a 1-year high of $1.35. The firm’s 50-day simple moving average is $0.33 and its 200-day simple moving average is $0.34. The firm has a market cap of $5.89 million, a P/E ratio of -0.95 and a beta of -1.04.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.